🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesNNT for MACE prevention — need advice

NNT for MACE prevention — need advice

MounjBrad Tue, Nov 18, 2025 at 10:36 PM 13 replies 976 viewsPage 1 of 3
MounjBrad
Member
278
890
Oct 2024
Kentucky
Nov 19, 2025 at 12:01 AM#1

NNT for MACE prevention — need advice

I've written this guide because I keep seeing the same questions come up about NNT for MACE prevention need advice. Rather than repeating myself across threads, here's everything in one place.

Who this is for: Anyone interested in nnt for mace prevention need advice, whether you're a newcomer or looking to deepen your understanding.

1. Overview

NNT for MACE prevention need advice is an important topic in the cardiovascular outcomes space. Understanding the fundamentals will help you make more informed decisions and have better conversations with your healthcare provider.

2. What the evidence says

The clinical trial data is extensive. Multiple randomized controlled trials (STEP, SURMOUNT, SUSTAIN, SURPASS programs) have established clear efficacy and safety benchmarks. I'll reference specific data points throughout this guide.

3. Practical recommendations

  • Start with the basics — don't overcomplicate things early on
  • Track your own data systematically (weight, labs, side effects)
  • Consult your healthcare provider before making any changes
  • Use this community as a supplement to — not a replacement for — professional medical care

4. Common mistakes

The most common errors I see: rushing titration, inadequate protein intake, not getting baseline labs, and relying on anecdotal reports over clinical data.

This guide is educational. It does not constitute medical advice. Last updated March 2026.

— MounjBrad | Cardiovascular Outcomes
37 19patPC_UT, Dr.DermMIA, fiona_VT and 34 others
Reply Quote Save Share Report
TrialNerd_Beth
Senior Member
2,345
11,234
Jan 2024
Bethesda, MD
Nov 19, 2025 at 12:18 AM#2

NNT for MACE prevention need advice — I actually dealt with this exact situation back in January.

Short answer: the data supports it for most people. Longer answer: I wrote about my experience in the compounding forum if you want the full details.

Last edited: Nov 19, 2025 at 4:18 AM
43 8PharmHunterJen, TomTeleRx, DoseLogDan and 40 others
Reply Quote Save Share Report
MikeFit_NJ
Senior Member
1,567
6,543
Apr 2024
New Jersey
Nov 19, 2025 at 12:35 AM#3

TrialNerd_Beth nailed it. Building on that — NNT for MACE prevention need is something I discuss with my PCP regularly, and their clinical perspective aligns with what TrialNerd_Beth described.

One thing I would add: the first few weeks are not representative of long-term results.

12 10DeniseRN_TPA, SandraNC_45, Dr.EndoIndy and 9 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
tyler_CSCS
Member
567
2,567
Jun 2024
Phoenix, AZ
Nov 19, 2025 at 12:52 AM#4

+1. This mirrors my journey exactly. The NNT for MACE discussion here is so valuable.

Last edited: Nov 19, 2025 at 2:52 AM
41 2amy_econ_NJ, bbq_ray_KC, oliver_london and 38 others
Reply Quote Save Share Report
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
Nov 19, 2025 at 1:09 AM#5

Clinical perspective on NNT for MACE prevention need advice:

I have managed over 200 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that proper titration prevents most adverse events.

For this specific question, I would recommend: reviewing the relevant clinical guidelines.

45 13mike_nyc, VendorMark, COA_Karl and 42 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register